FDA: Out-Of-Spec Components May Be Used In Finished Devices - But Beware
This article was originally published in The Gray Sheet
Manufacturers may knowingly use out-of-specification components from suppliers as long as the quality of finished devices is not compromised, FDA says
You may also be interested in...
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.
Butterfly Network is disseminating the lessons from China and Italy about the poential value of lung ultrasound in the management of COVID-19 patients with respiratory disease.